A miRNA-gene interaction network revealed that several of these miRNAs target key oncogenic pathways, including EZH2, MYC, and TP53 (Table 1), suggesting a potential role in promoting glioma aggressiveness and therapy resistance. This evidence concerns the gene EZH2 and central nervous system cancer.